Wells Fargo’s Lucid Diagnostics LUCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$261K Buy
226,860
+224,710
+10,452% +$258K ﹤0.01% 4227
2025
Q1
$3.2K Sell
2,150
-150
-7% -$223 ﹤0.01% 5626
2024
Q4
$1.88K Sell
2,300
-163
-7% -$133 ﹤0.01% 5692
2024
Q3
$2.01K Sell
2,463
-1,000
-29% -$815 ﹤0.01% 5645
2024
Q2
$2.84K Sell
3,463
-11,042
-76% -$9.06K ﹤0.01% 5579
2024
Q1
$11.7K Buy
14,505
+5,424
+60% +$4.39K ﹤0.01% 5324
2023
Q4
$12.8K Buy
9,081
+4
+0% +$6 ﹤0.01% 5328
2023
Q3
$10.6K Buy
9,077
+8,983
+9,556% +$10.5K ﹤0.01% 5425
2023
Q2
$131 Buy
94
+35
+59% +$49 ﹤0.01% 6504
2023
Q1
$83 Buy
59
+1
+2% +$1 ﹤0.01% 6653
2022
Q4
$79 Buy
58
+2
+4% +$3 ﹤0.01% 6528
2022
Q3
$0 Buy
56
+20
+56% ﹤0.01% 6744
2022
Q2
$0 Sell
36
-1,063
-97% ﹤0.01% 6898
2022
Q1
$4K Sell
1,099
-2,009
-65% -$7.31K ﹤0.01% 6174
2021
Q4
$16K Buy
+3,108
New +$16K ﹤0.01% 5877